<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02886949</url>
  </required_header>
  <id_info>
    <org_study_id>CE11307</org_study_id>
    <nct_id>NCT02886949</nct_id>
  </id_info>
  <brief_title>The Association Between Autoimmune or Inflammation and Thyroid Disease</brief_title>
  <official_title>The Relationship of Vascular Cell Adhesion Molecule 1, C-reactive Protein, Brain-derived Neurotrophic Factor, Orexin and Depressive Symptoms in the Subjects With Thyroid Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taichung Veterans General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taichung Veterans General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate the effects of thyroid functions on energy homeostasis and
      inflammation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The subjects were enrolled for evaluation of thyroid functions. The associations between
      thyroid function and energy homeostasis and inflammation will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>brain-derived neurotrophic factor</measure>
    <time_frame>3 months</time_frame>
    <description>BDNF</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>vascular cell adhesion molecule 1 (VCAM-1)</measure>
    <time_frame>3 months</time_frame>
    <description>Inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive protein (CRP)</measure>
    <time_frame>3 months</time_frame>
    <description>Inflammation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Orexin</measure>
    <time_frame>3 month</time_frame>
    <description>Psychological assessment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zung Self-Rating Depression Scale (Zung SDS)</measure>
    <time_frame>3 month</time_frame>
    <description>Depressive symptom</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>3 month</time_frame>
    <description>fat component</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ankle brachial index (ABI)</measure>
    <time_frame>3 months</time_frame>
    <description>Arterial stiffness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulse wave velocity (PWV)</measure>
    <time_frame>3 months</time_frame>
    <description>Arterial stiffness</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial pressure (MAP)</measure>
    <time_frame>3 months</time_frame>
    <description>Arterial stiffness</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>THYROTOXICOSIS</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples and urine samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with a suspicion of thyroid disease.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects visits outpatient department due to a suspicion of thyroid disease

        Exclusion Criteria:

          -  Psychological disorders, severe inflammatory or infection diseases.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>I-Te Lee, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Taichung Veterans General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>I-Te Lee, MD</last_name>
    <email>itlee@vghtc.gov.tw</email>
  </overall_contact>
  <location>
    <facility>
      <name>Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital</name>
      <address>
        <city>Taichang</city>
        <zip>407</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>I-TE Lee, MD</last_name>
      <email>itlee@vghtc.gov.tw</email>
    </contact>
    <contact_backup>
      <last_name>Wayne HH SHEU, MD, PhD</last_name>
      <email>whhsheu@vghtc.gov.tw</email>
    </contact_backup>
    <investigator>
      <last_name>I-Te Lee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wayne HH Sheu, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 2, 2015</study_first_submitted>
  <study_first_submitted_qc>August 26, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>March 24, 2018</last_update_submitted>
  <last_update_submitted_qc>March 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyrotoxicosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

